Hung-Keng Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hung-Keng Li has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Bing-Juin Chiang
Department of Life Science, School of Life Science, National Taiwan Normal University, Taipei, Taiwan
1 shared publication - Chao-Hsiang Chang
Department of Urology, China Medical University and Hospital, Taichung 404327, Taiwan
1 shared publication - Chao-Yuan Huang
Department of Urology, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan
1 shared publication - Chia-Chang Wu
Department of Urology, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan
1 shared publication - Chin-Chung Yeh
Department of Urology, China Medical University and Hospital, Taichung 404327, Taiwan
1 shared publication - Chung-Hsin Chen
Department of Urology, National Taiwan University Hospital, Taipei, Taiwan
1 shared publication
Latest Publications
- Open Access
- 28 February 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (3) , 554
Factors Affecting Oncological Outcomes in Upper Tract Urothelial Carcinoma Patients with Chronic Kidney Disease and End-Stage Renal Disease
Background/Objectives: We assessed factors affecting the oncological outcomes in upper tract urothelial carcinoma patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) in Taiwan, using a large domestic upper tract urothelial carcinoma collaboration database. Methods: From July 1988 to December 2019, 15 hospitals joined the Taiwan Upper Tract Urothelial Carcinoma Collaboration Group. A total of 690 patients were included, and demographic, clinical, and pathological data were compared. Factors related to overall survival, cancer-specific survival, disease-free survival, and bladder recurrence-free survival were analyzed. Results: Out of the 690 patients, 605 had CKD and 85 had ESRD. In multivariate analysis, overall survival was associated with CKD stage (p = 0.024), age > 70 years (p = 0.002), and pathological stage III/IV (p = 0.014 and p = 0.041), positive surgical margin (p = 0.005), and pathological stage III/IV (p = 0.010 and p = 0.001), lower ureter tumors (p = 0.010), and pathological stage III/IV (p = 0.039 and p = 0.027), lower ureter tumors (p = 0.027), coronary artery disease (p = 0.047), and arrhythmias (p = 0.044) were associated with bladder recurrence-free survival. Conclusions: The oncological outcomes of UTUC patients with CKD and ESRD in Taiwan were affected by various factors. Tumor location and advanced pathological stage were related to OS, CSS, and DFS. Cardiac diseases were possibly related to BRFS.
- 28 February 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (3) , 554
Open AccessFactors Affecting Oncological Outcomes in Upper Tract Urothelial Carcinoma Patients with Chronic Kidney Disease and End-Stage Renal Disease
Background/Objectives: We assessed factors affecting the oncological outcomes in upper tract urothelial carcinoma patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) in Taiwan, using a large domestic upper tract urothelial carcinoma collaboration database. Methods: From July 1988 to December 2019, 15 hospitals joined the Taiwan Upper Tract Urothelial Carcinoma Collaboration Group. A total of 690 patients were included, and demographic, clinical, and pathological data were compared. Factors related to overall survival, cancer-specific survival, disease-free survival, and bladder recurrence-free survival were analyzed. Results: Out of the 690 patients, 605 had CKD and 85 had ESRD. In multivariate analysis, overall survival was associated with CKD stage (p = 0.024), age > 70 years (p = 0.002), and pathological stage III/IV (p = 0.014 and p = 0.041), positive surgical margin (p = 0.005), and pathological stage III/IV (p = 0.010 and p = 0.001), lower ureter tumors (p = 0.010), and pathological stage III/IV (p = 0.039 and p = 0.027), lower ureter tumors (p = 0.027), coronary artery disease (p = 0.047), and arrhythmias (p = 0.044) were associated with bladder recurrence-free survival. Conclusions: The oncological outcomes of UTUC patients with CKD and ESRD in Taiwan were affected by various factors. Tumor location and advanced pathological stage were related to OS, CSS, and DFS. Cardiac diseases were possibly related to BRFS.